Rare disease patients often face lengthy diagnostic delays due to fragmented clinical data and nonspecific symptoms. Join us for this session to explore how artificial intelligence (AI) and integrated real-world data (RWD)—including electronic health records, medical and pharmacy claims, laboratory results, and diagnostic testing data—can help identify patients who may have an undiagnosed rare disease.
You’ll learn about:
How AI-powered analytics can be leveraged to uncover meaningful clinical patterns within healthcare provider patient populations, enabling earlier recognition of individuals at risk
Ways data-driven insights can support targeted engagement with treating healthcare providers, reinforcing appropriate clinical evaluation and diagnostic testing
Best practices for effectively combining advanced analytics with personalized provider outreach
